News

Archived: Novartis Acquires Selexys Pharmaceuticals Corporation, SelG1 Antibody for Pain Reduction in Sickle Cell Disease

Novartis (No. 2 on the DiversityInc Top 50 Companies list) announced it has acquired Selexys Pharmaceuticals Corporation, a company specializing in development of therapeutics in certain hematologic and inflammatory disorders. Novartis exercised its right to acquire Selexys following receipt of results of the SUSTAIN study, a Phase II trial evaluating…

Archived: Trump's Chief of Staff: Won't 'Rule out' a Muslim Registry

Reince Priebus, President-elect Donald Trump’s chief of staff, made numerous contradictory remarks regarding requiring Muslims to register in a national database. During an interview for “Meet the Press” Sunday, when host Chuck Todd asked if Priebus has ruled out a registry as a possibility, Priebus said that nothing was off…